Related Experiment Videos
A systematic appraisal of portacaval H-graft diameters. Clinical and hemodynamic perspectives
Insights
Smaller portacaval H-grafts (8-10 mm) effectively reduce encephalopathy and prevent rebleeding in cirrhosis patients. This approach achieves partial portal flow shunting, preserving prograde hepatic flow and improving patient outcomes.
Area of Science:
- Hepatology
- Vascular Surgery
- Gastroenterology
Background:
- Cirrhosis often leads to variceal hemorrhage, a life-threatening complication.
- Portacaval shunts are used to decompress the portal system, but can cause complications like hepatic encephalopathy.
- Optimizing shunt diameter is crucial for balancing decompression and preserving hepatic blood flow.
Purpose of the Study:
- To evaluate the clinical and hemodynamic effects of systematically reduced portacaval H-graft diameters.
- To determine if smaller grafts can achieve partial portal flow shunting without reversing hepatic flow.
- To assess the impact of graft size on portal pressure, encephalopathy, and rebleeding rates.
Main Methods:
- A 10-year study involving 68 patients with cirrhosis and variceal hemorrhage.
- Portacaval H-grafts with diameters ranging from 20 to 8 mm were implanted.
- Clinical data and hemodynamic parameters, including portal flow and pressure, were systematically collected and analyzed.
Main Results:
- Reduced shunt diameters (10-8 mm) combined with collateral ablation significantly increased portal pressures compared to larger grafts.
- Prograde portal flow was observed in 46% and 82% of patients with 10 mm and 8 mm grafts, respectively, versus 3% with 20-12 mm grafts.
- Encephalopathy incidence decreased from 39% (20-12 mm grafts) to 19% (10 mm) and 9% (8 mm grafts). No rebleeding occurred in patients with 8-10 mm PTFE grafts.
Conclusions:
- Partial shunting of portal flow is hemodynamically feasible using smaller polytetrafluoroethylene (PTFE) portacaval H-grafts (8 mm) combined with portal collateral ablation.
- Preserving prograde portal flow through partial shunting correlates with reduced post-operative encephalopathy.
- Smaller portacaval H-grafts effectively prevent variceal rebleeding despite maintaining a relatively hypertensive portal system.
Abstract:
Over a period of 10 years, the authors have systematically reduced portacaval H-graft diameters. Their objective was to achieve partial shunting of portal flow without reversal of hepatic flow. This report summarizes their clinical and hemodynamic observations in 68 surviving patients with cirrhosis (mostly alcoholic) and variceal hemorrhage who underwent portacaval H-grafts ranging from 20 to 8 mm diameters. When shunt diameters were reduced to 10 and 8 mm and combined with aggressive portal collateral ablation, portal pressures increased significantly over larger H-grafts. Only 3% of patients with 20-12 mm H-grafts had prograde portal flow after operation, compared with 46 and 82% after 10 and 8 mm H-grafts, respectively (p less than 0.001). The incidence of encephalopathy diminished from 39% in the 20-12 mm H-graft group to 19 and 9% after 10 and 8 mm grafts, respectively (p less than 0.04). None of the patients with 10 or 8 mm PTFE grafts rebled from varices in the follow-up period (4-61 months). It is concluded that partial shunting of portal flow is hemodynamically feasible. It can be achieved in most patients using 8 mm polytetrafluoroethylene (PTFE) portacaval H-grafts combined with portal collateral ablation. Preserving prograde portal flow by partial shunting correlates with reduced encephalopathy rates after operation. Despite maintaining a relatively hypertensive portal system, partial shunts effectively prevent variceal hemorrhage.